|Year : 2015 | Volume
| Issue : 4 | Page : 419-424
Calotropis procera : A potential cognition enhancer in scopolamine and electroconvulsive shock-induced amnesia in rats
Rohit Malabade, Ashok D Taranalli
Department of Pharmacology, KLE University's College of Pharmacy, Belagavi, Karnataka, India
|Date of Submission||19-May-2015|
|Date of Decision||19-Jun-2015|
|Date of Acceptance||26-Jun-2015|
|Date of Web Publication||21-Jul-2015|
[email protected] Rohit Malabade
Department of Pharmacology, KLE University's College of Pharmacy, Belagavi, Karnataka
Source of Support: None, Conflict of Interest: None
Objectives: Present study evaluates the effect of Calotropis procera (Apocynaceae) dry latex on cognitive function in rats using scopolamine and electroconvulsive shock (ECS) induced amnesia model.
Materials and Methods: Male Wistar rats were pretreated with 200, 400 and 800 mg/kg of C. procera dry latex in scopolamine-induced amnesia model. Dose showing maximum effect in cognitive performance was selected and further evaluated using scopolamine and ECS-induced amnesia model for its effect on neurochemical enzymes and cognitive performance. Acetylcholinesterase (AChE) activity, β amyloid 1-42 , and dopamine level were analyzed, while the cognitive performance was assessed by elevated plus maze, step-through passive avoidance test, and Morris water maze. Simultaneously, C. procera dry latex (25, 50, 100, 250, 500, and 1000 μg/mL) was screened for in vitro AChE inhibition assay.
Results: Pretreatment with (200, 400 and 800 mg/kg) C. procera dry latex shows dose dependent increase in cognitive performance in scopolamine-induced amnesia. Further, pretreatment with the selected dose (800 mg/kg) showed significant improvement in transfer latency (P < 0.001, P < 0.01), escape latency (P < 0.05), time spent in target quadrant (P < 0.001) also significant decrease in AChE activity (P < 0.05), β amyloid 1-42 level (P < 0.001), and increase in dopamine level (P < 0.01) in rat brain homogenate when compared with scopolamine and ECS disease control groups. IC 50 for C. procera dry latex was found to be <1000 μg/mL.
Conclusions: Pretreatment with C. procera dry latex (800 mg/kg) produced significant cognition enhancement by improving cognitive performance and decreasing the marker neurochemical enzyme activity in scopolamine and ECS-induced amnesia model.
Keywords: Acetylcholinesterase, Alzheimer′s disease, Dopamine, β amyloid1-42
|How to cite this article:|
Malabade R, Taranalli AD. Calotropis procera : A potential cognition enhancer in scopolamine and electroconvulsive shock-induced amnesia in rats. Indian J Pharmacol 2015;47:419-24
|How to cite this URL:|
Malabade R, Taranalli AD. Calotropis procera : A potential cognition enhancer in scopolamine and electroconvulsive shock-induced amnesia in rats. Indian J Pharmacol [serial online] 2015 [cited 2021 Jun 23];47:419-24. Available from: https://www.ijp-online.com/text.asp?2015/47/4/419/161269
| » Introduction|| |
Cognitive impairment is one of the most common condition and a major health problem in the geriatric population. Progressive loss of cognitive ability is a primary characteristic of Alzheimer's disease, which particularly affects daily activities such as memory, learning, and problem solving,  also decreased cholinergic transmission and rise in oxidative stress, neuroinflammatory reactions in brain is a reason for cognitive impairment. 
In the present study, scopolamine and electroconvulsive shock (ECS) induced amnesia was used as a pharmacological model. Scopolamine a muscarinic receptor antagonist interferes with central cholinergic functions and process of memory and learning which lead to cognitive decline in animals.  ECS is an animal model of seizure induction that typically induces amnesia. ECS produces both anterograde and retrograde amnesia. ECS affects different region of brain, it is likely to have different molecular pathways which all together contribute to cognitive impairment in rats. 
The pathophysiology of cognition impairment is complex and involves several different biochemical pathways. In recent years, herbal remedies are reported to contain several active compounds which made them a popular choice to enhance cognitive function and to alleviate other functions associated with cognitive disorders.  Calotropis procera (Asclepiadaceae) is an important medicinal plant, which was used as a drug of choice for various ailments in ancient time.  Pharmacological properties of C. procera are associated with its latex, which is rich in biologically active compounds like cardenolides, triterpenoids, resins, proteolytic enzymes, flavonoids, tannins, sterol, and terpenes.  Pharmacologically, latex has proved to possess potent anti-inﬂammatory, analgesic activity.  The free radical scavenging and antioxidant property is comparable to standard antioxidant (Vitamin C)  and also root extract of C. procera possess anticonvulsant activity. 
Potential of C. procera latex has been proved scientifically for the treatment of various diseases including central nervous system disorders, but the cognition-enhancing property of C. procera latex on rats is not well understood. Therefore, the study was undertaken to investigate the effect of C. procera dry latex on cognitive function in rats using scopolamine and ECS-induced amnesia model.
| » Materials and Methods|| |
Collection and Preparation of Plant Material
The C. procera plant was identiﬁed in Belagavi District, Karnataka, India and was authenticated by Dr. Harsha Hegde, Scientist F, Regional Medical Research Centre, Belagavi, Karnataka, India, whereas herbarium is preserved for future reference. The latex was collected from the aerial parts of the plant. It was dried under shade at ambient temperature. The dry latex was triturated with water and aqueous suspension thus obtained was administered orally to rats.
The study was carried out in Male Wistar rats (150-200 g). Animals were kept in plastic cages in room with a controlled temperature of 25 ± 2°C, 12/12 h light/dark cycle, food, and water ad libitum. The rats were acclimatized for a period of 1-week before starting the experiments. All the experimental procedures were performed between 9 am and 4 pm. Before commencement of the experiment, animal ethical approval was obtained from the Institutional Animal Ethical Committee.
In vitro Acetylcholinesterase Microplate Inhibition Assay
Acetylcholinesterase (AChE) activity was measured using a modified 96-well microplate assay  based on Ellman's method.  The test compound solution having concentration 25, 50, 100, 250, 500, and 1000 μg/mL (20 μL) and AChE (20 μL) were mixed and incubated for 15 min (25°C). The reaction was then initiated by the addition of acetylthiocholine (10 μL). The hydrolysis of acetylthiocholine was monitored by the formation of yellow color, that is, 5-thio-2-nitrobenzoate anion at 412 nm for every 5 min over 20 min using a 96-well microplate reader (Thermo Scientific, Multiskan GO). The IC 50 values were calculated using a software program.
C. procera dry latex was screened using scopolamine-induced amnesia model, by administrating three doses, that is, 200, 400, and 800 mg/kg. For this rats were divided into six groups (n = 6 animal/group) Group 1 - normal control, Group 2 - disease control (scopolamine, 3 mg/kg, i.p.), Group 3 - standard control (Mentat - 100 mg/kg, p.o. for 14 days), and Groups 4-6 - received 200, 400, and 800 mg/kg of C. procera dry latex p.o. for 14 days. The acquisition trail for elevated plus maze, step-through passive avoidance, and Morris water maze was carried on 14 th day and retention was tested on 15 th day. Dose showing maximum activity in scopolamine-induced amnesia model was selected.
Selected dose was further evaluated by scopolamine and ECS-induced amnesia model for its effect on AChE activity, β amyloid 1-42 , dopamine concentration in rat brain homogenate and for its cognitive performance in elevated plus maze, step-through passive avoidance, and Morris water maze. For this study, rats were divided into seven groups; Group 1 - normal control, Group 2 - scopolamine, 3 mg/kg, i.p., Group 3 - scopolamine + Mentat (100 mg/kg, p.o.), Group 4 - scopolamine + C. procera dry latex (800 mg/kg, p.o.), Group 5 - received ECS (10 mA current for 0.2 s), Group 6 - ECS + Mentat (100 mg/kg), Group 7 - ECS + C. procera dry latex (800 mg/kg). Mentat and C. procera dry latex was administered orally for 14 days, while scopolamine and ECS was administered after acquisition trail (14 th day) which provoked cognitive impairment in rats.
An electric current (60 Hz, 2 s, and 20 mA) was delivered to the restrained rat by applying the corneal electrodes of the ECS apparatus. The shock was delivered immediately after the acquisition trial in disease control and treatment groups. 
Elevated Plus Maze
The apparatus consists of a wooden structure, raised to a height of 40 cm from the ﬂoor. This apparatus is composed of four arms, two closed and two open arms. In acquisition trail, each rat was placed at the end of an open arm facing away from the center. The time taken to enter any one of the closed arms was recorded as transfer latency. All four legs inside the closed arm are counted as an entry. Cut off time allotted for each rat was 180 s. Retention trail was conducted 24 h after the first trial and transfer latency was recorded. Shortened transfer latency was considered as an index of improvement of memory. 
Step through Passive Avoidance Test
The apparatus consisted of a light and dark compartment connected by an opaque guillotine door. The floors of both compartments were made of stainless steel rods (3 mm diameter) spaced 1 cm apart. Acquisition trail: The rats were placed in the light compartment and 5 s later the guillotine door was raised. Rats have natural preference for the dark environment. The latency to enter the dark compartment (escape latency) was recorded when the animal had placed all four paws in the dark compartment. After the animal had spontaneously entered the dark compartment, the guillotine door was lowered, and a mild electrical shock (0.5 mA) was applied for 2 s. After 30 s, the rat was removed from the dark compartment and returned to its home cage. Retention test: Escape latency was recorded during the retention trial and if the rat did not enter the dark compartment within 300 s, the retention test was terminated and a ceiling score of 300 s was assigned. 
Morris Water Maze Test
It consists of circular pool ﬁlled with water, a platform (10 cm × 10 cm) was submerged 2 cm below the water surface. Each rat was given four trials on each testing day for 4 days and retention of memory was tested on 5 th day. The starting position was randomized over each testing day but remained same for all the rats in each trial. During each trial, the rat was placed in the water with its head pointed toward the side wall and allowed 90 s to search for the hidden platform. One day before the test, each rat was placed in the pool for 60 s; this free swim enabled the rat to become habituated to the training environment. If the rat did not find the platform in 120 s, it was manually placed on the platform for a 30 s rest. Whereas on day 5, time spent in target quadrant (Q4) served as an index of retrieval or memory. 
Assay of Acetylcholinesterase Activity
Rats were sacrificed by cervical dislocation and whole brain was dissected out, 20 mg of brain tissue/mL of phosphate buffer (0.1 M; pH 8) was homogenized and 0.4 mL aliquot of brain homogenate was added to a cuvette containing 2.6 mL of 0.1 M phosphate buffer, 100 μL of 5.5'- dithiobis-2-nitrobenzoic acid reagent. The substrate acetylthiocholine iodide 20 μL was added and change in optical absorbance was measured every 2 min for 10 min at 412 nm to provide a measure of enzyme activity. 
Estimation of Dopamine
The content of dopamine in the brain tissue was determined as per the method described by Schlumpf et al. 
Estimation of β Amyloid 1-42
The content of β amyloid 1-42 in the brain tissue was determined according to the manual of sandwich ELISA kit for rat β amyloid 1-42 (YH Bioresearch Laboratory, Shanghai, China).
The results were expressed as mean ± standard error of mean. The statistical signiﬁcance was determined by one-way analysis of variance followed by Dunnett's test. P < 0.05 was considered to be statistically signiﬁcant.
| » Results|| |
In vitro Acetylcholinesterase Microplate Inhibition Assay
C. procera dry latex was found to be active at all concentrations (25, 50, 100, 250, 500, and 1000 μg/mL) in in vitro AChE microplate inhibition assay and IC 50 was found out to be <1000 μg/mL.
Part I: Screening of Calotropis procera using Scopolamine-induced Amnesia
Three different doses (200, 400, and 800 mg/kg) of C. procera dry latex was administered in scopolamine-induced amnesia model. At a dose of 800 mg/kg, transfer latency was significantly decreased (P < 0.001) in elevated plus maze, also significant increase (P < 0.01) was observed in step-through latency and time spent in Q4 was significantly increased in Morris water maze when compared with disease control group as indicated in [Table 1].
|Table 1: Effect of CP-200, 400 and 800 mg/kg dose on transfer latency, escape latency, and time spent on target quadrant (Q4) using scopolamine-induced amnesia model in rats |
Click here to view
Part II: Evaluation of Calotropis procera (800 mg/kg) using Scopolamine and Electroconvulsive Shock-Induced Amnesia
Elevated plus maze
Retention trial showed a significant increase in transfer latency in scopolamine (P < 0.01) and ECS (P < 0.5) disease control groups indicating cognitive impairment in rats. Pretreatment with C. procera dry latex significantly decreased transfer latency in Sco + C. procera (800 mg/kg) (P < 0.001) and ECS + C. procera (800 mg/kg) (P < 0.01) group when compared with respective disease control groups [Figure 1].
|Figure 1: Effect of Calotropis procera (Calotropis procera 00 mg/kg) extract on transfer latency in scopolamine and electroconvulsive shock-induced amnesia. All values represent mean ± standard error of mean. ***P < 0.001, **P < 0.01, *P < 0.05 vs disease control|
Click here to view
Step through passive avoidance test
Administration of scopolamine (P < 0.01) and ECS (P < 0.05) decreased step down latency, while pretreatment with C. procera dry latex (800 mg/kg) markedly increased (P < 0.05) escape latency and reversed scopolamine-induced cognitive impairment. Furthermore, rats treated with Mentat also showed increase (P < 0.001) in escape latency [Figure 2].
|Figure 2: Effect of Calotropis procera (Calotropis procera - 800 mg/kg) on step-through latency in scopolamine and electroconvulsive shock-induced amnesia. All values represent mean ± standard error of mean. ***P < 0.001, **P < 0.01, *P < 0.05 versus disease control|
Click here to view
Morris water maze
Pretreatment with C. procera dry latex (800 mg/kg) showed significant increase (P < 0.001) in time spent in Q4 when compared with scopolamine (P < 0.01) and ECS (P < 0.01) disease control groups [Figure 3].
|Figure 3: Effect of Calotropis procera (Calotropis procera - 800 mg/kg) on time spent in target quadrant in scopolamine and electroconvulsive shock-induced amnesia. All values represent mean ± standard error of mean. ***P < 0.001, **P < 0.01, *P < 0.05 versus disease control|
Click here to view
Pretreatment with C. procera dry latex (800 mg/kg) significantly reduced (P < 0.05) the AChE activity as compared to disease control groups (P < 0.01). Mentat also significantly decreased AChE activity in Sco + Mentat (P < 0.01) group and ECS + Mentat (P < 0.05) as indicated in [Figure 4].
|Figure 4: Effect of Calotropis procera (Calotropis procera - 800 mg/kg) on Acetylcholinesterase enzyme activity in scopolamine and electroconvulsive shock-induced amnesia. All values represent mean ± standard error of mean. ***P < 0.001, **P < 0.01, *P < 0.05 versus disease control|
Click here to view
Exposure to scopolamine and ECS significantly reduced (P < 0.001) level of dopamine in disease control groups and pretreatment with C. procera significantly increased (P < 0.01) level of dopamine when compared with disease control groups [Figure 5].
|Figure 5: Effect of Calotropis procera (Calotropis procera - 800 mg/kg) on concentration of dopamine in scopolamine and electroconvulsive shock-induced amnesia. All values represent mean ± standard error of mean. ***P < 0.001, **P < 0.01, *P < 0.05 versus disease control|
Click here to view
β amyloid 1-42 level
Scopolamine and ECS administered group showed significant increase (P < 0.001) in β amyloid 1-42 levels when compared with normal control, while significant fall in (P < 0.001) β amyloid 1-42 level was observed in pretreated groups when compared with disease control [Figure 6].
|Figure 6: Effect of Calotropis procera (Calotropis procera - 800 mg/kg) on concentration of β amyloid1-42 in scopolamine and electroconvulsive shock-induced amnesia. All values represent mean ± standard error of mean. ***P < 0.001, **P < 0.01, *P < 0.05 versus disease contro|
Click here to view
| » Discussion|| |
Present study investigated the effect of C. procera dry latex on scopolamine and ECS-induced amnesia in rats using elevated plus maze which is used to screen drugs used in learning and memory. The step-through passive avoidance test generally accepted as an indicator of long-term memory in animals. Morris water maze was used to assess hippocampal-dependent spatial learning ability.  Furthermore, AChE activity, β amyloid 1-42 level, and dopamine concentration were analyzed from rat brain homogenate.
C. procera dry latex was administered at three doses (200, 400, and 800 mg/kg) in scopolamine-induced amnesia model and results revealed a dose dependent effect. The higher dose (800 mg/kg) being able to produce significant results in elevated plus maze, step-through passive avoidance, and Morris water maze, which was comparable with the standard. Further, 800 mg/kg dose was selected to evaluate the effect of C. procera dry latex on cognitive performance and biochemical changes using scopolamine and ECS-induced amnesia model.
Pretreatment with C. procera dry latex (800 mg/kg) in scopolamine and ECS-induced amnesia model demonstrated a significant reduction of transfer latency in elevated plus maze, significant elevation of escape latency in passive avoidance test. Also in Morris water maze the mean time spent in the Q4 was significantly increased during the retention trial. The results show that C. procera dry latex (800 mg/kg) improved the cognitive performance in scopolamine and ECS-induced cognitive impairment in rats.
Increase in cholinergic activity and inhibition of AChE enzyme is a promising therapy to treat a cognitive defect in Alzheimer's disease.  Administration of C. procera dry latex (800 mg/kg) significantly reversed the elevated AChE level in scopolamine and ECS-induced rats. Hence, these results suggest that cognition enhancing the property of C. procera dry latex may be due to inhibition of AChE enzyme.
Cognition impairment is characterized by plaque deposition in extracellular spaces by aggregation of β amyloid protein in brain tissue, and β amyloid 1-42 is found predominantly in brain. Extracellular deposition of β amyloid is considered as a biomarker for Alzheimer's disease.  Pretreatment with C. procera dry latex (800 mg/kg) demonstrated a significant decrease in the amount of β amyloid 1-42 in rat brain. These results were in co-relation with a previous report by Zhao et al. 
In stressful conditions, change in dopamine level is associated with a transient change in behavioral aberrations, memory learning disorders.  Administration of C. procera dry latex (800 mg/kg) increased dopamine concentration in scopolamine and ECS-induced amnesia model after 14 days of pretreatment. Hence, C. procera dry latex may show cognition enhancement by increasing dopamine level.
C. procera dry latex inhibit AChE enzyme at 25, 50, 100, 250, 500, and 1000 μg/mL concentration in in vitro AChE inhibition microplate assay and IC 50 was found to be <1000 μg/mL. These results provide evidence that C. procera dry latex inhibits AChE enzyme activity.
Hence, pretreatment with C. procera dry latex (800 mg/kg) demonstrated a significant reversal of cognition impairment in rats by inhibition of AChE enzyme, increasing dopamine level, decreasing β amyloid 1-42 in rat brain, and also by improving cognitive performance in scopolamine and ECS-induced amnesia model.
| » Conclusions|| |
The study provides evidence that C. procera dry latex exhibits multiple pathways for cognition enhancement in scopolamine and ECS-induced amnesia model. Beneficial effect of C. procera dry latex on cognition may be due to its rich content of biologically active compounds. Further, the study is required to isolate compounds responsible for cognition-enhancing property.
The author is thankful to Dr. Harsha Hegde, Scientist F, Regional Medical Research Centre, Belagavi, Karnataka, India for providing the facilities to carry out some of the studies.
Financial Support and Sponsorship
Conflicts of Interest
There are no conflicts of interest.
| » References|| |
Yankner BA. Mechanisms of neuronal degeneration in Alzheimer′s disease. Neuron 1996;16:921-32.
Youdim MB, Buccafusco JJ. Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders. Trends Pharmacol Sci 2005;26:27-35.
Klinkenberg I, Blokland A. The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies. Neurosci Biobehav Rev 2010;34:1307-50.
Andrade C. Molecular mechanisms underlying electroconvulsive therapy-induced amnestic deficits: A decade of research. Indian J Psychiatry 2008;50:244-52.
Mukherjee PK, Kumar V, Mal M, Houghton PJ. Acetylcholinesterase inhibitors from plants. Phytomedicine 2007;14:289-300.
Kumar A, Yadav A, Rao M. Ayurvedic uses and pharmacological activities of Calotropis procera
Linn. Asian J Tradit Med 2011;6:45-53.
Jucá TL, Ramos MV, Moreno FB, Viana de Matos MP, Marinho-Filho JD, Moreira RA, et al.
Insights on the phytochemical profile (cyclopeptides) and biological activities of Calotropis procera
latex organic fractions. Scientific World Journal 2013;2013:615454.
Mossa JS, Tariq M, Mohsin A, Ageel AM, Al-Yahya MA, Al-Said MS, et al.
Pharmacological studies on aerial parts of Calotropis procera
. Am J Chin Med 1991;19:223-31.
Joshi R, Sharma A, Bhanwar LJ. Analysis of antioxidant activity in extracts of Calotropis procera
(Ait.) R.Br. J Appl Biosci 2009;17:899-903.
Jalalpure SS. Anticonvulsant effects of Calotropis procera
root in rats. Pharm Biol 2009;47:162-7.
Ingkaninan K, Temkitthawon P, Chuenchom K, Yuyaem T, Thongnoi W. Screening for acetylcholinesterase inhibitory activity in plants used in Thai traditional rejuvenating and neurotonic remedies. J Ethnopharmacol 2003;89:261-4.
Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
Neha S,Sodhi RK, Jaggi AS, Singh N. Animal models of dementia and cognitive dysfunction. Life Sci 2014;109:73-86.
Kamath S, et al
. Evaluation of the effect of Ferula asafoetida
Linn. gum extract on learning and memory in wistar rats. Indian J Pharmacol 2012;44:52-7.
Yadav KD, Reddy K, Kumar V. Encouraging effect of Brahmi ghrita
in amnesia. Int J Green Pharm 2013;7:122-6.
Chakravarti K, Avadhani R. Beneficial effect of aqueous extract of Glycerrizaglabra
on learning and memory using different behavioural models: An experimental study. J Nat Sci Bio Med 2013;4:420-6.
Schlumpf M, Lichtensteiger W, Langemann H, Waser PG, Hefti F. A fluorometric micromethod for the simultaneous determination of serotonin, noradrenaline and dopamine in milligram amounts of brain tissue. Biochem Pharmacol 1974;23:2437-46.
Gutierres J. Neuroprotective effect of anthocyanins on acetylcholinesterase activity and attenuation of scopolamine induced amnesia in rats. Int J Dev Neurosci 2014;33:88-97.
Agrawal R, Tyagi E, Saxena G, Nath C. Cholinergic influence on memory stages: A study on scopolamine amnesic mice. Indian J Pharmacol 2009;41:192-6.
Parcha U Z, Qadri I, Hayat K, Hussain T. Biomarkers for Alzheimer′s disease and potential future directions. Aging Neurodegener 2013;1:125-9.
Zhao L, Wang JL, Liu R, Li XX, Li JF, Zhang L. Neuroprotective, anti-amyloidogenic and neurotrophic effects of apigenin in an Alzheimer′s disease mouse model. Molecules 2013;18:9949-65.
Muralidharan P, Balamurugan G, Venu B. Cerebroprotective effect of Glycyrrhizaglabra
Linn. root extract on hypoxic rats. Bangladesh J Pharmacol 2009;4:60-4.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6]